SCHEMBL852610

SCHEMBL852610

BrC1C=CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL551176 0.97
SCHEMBL551175 0.97
SCHEMBL239631 0.92
SCHEMBL5606894 0.79
SCHEMBL11287030 0.78 ALDH1A1 (0.31)
SCHEMBL11287028 0.78 ALDH1A1 (0.31)
SCHEMBL11288135 0.72
SCHEMBL17871004 0.71
SCHEMBL711453 0.71
SCHEMBL1232859 0.71 KDM4E (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113816818-B Copper-catalyzed asymmetric allylic alkylation reaction method and chiral compound 哈尔滨工业大学(深圳) 2023-07-25 CN claimed
CN-114149421-A Palmatine derivative, preparation method and antithrombotic application thereof 中国医学科学院医药生物技术研究所 2022-03-08 CN claimed
CN-113816818-B Copper-catalyzed asymmetric allylic alkylation reaction method and chiral compound 哈尔滨工业大学(深圳) 2023-07-25 CN disclosed
CN-114149421-B Palmatine derivatives, preparation method and antithrombotic use thereof 中国医学科学院医药生物技术研究所 2023-04-25 CN disclosed
CN-114149421-A Palmatine derivative, preparation method and antithrombotic application thereof 中国医学科学院医药生物技术研究所 2022-03-08 CN disclosed
CN-113816818-A Copper-catalyzed asymmetric allyl alkylation reaction method and chiral compound 哈尔滨工业大学(深圳) 2021-12-21 CN disclosed
EP-3564240-A1 PIPERIDINE INTERMEDIATES Purdue Pharma L.P. (US) 2019-11-06 EP disclosed
US-9527840-B2 Substituted-quinoxaline-type piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2016-12-27 US disclosed
US-9527840-B2 Substituted-quinoxaline-type piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2016-12-27 US disclosed
US-9527840-B2 Substituted-quinoxaline-type piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2016-12-27 US disclosed
EP-3101018-A1 SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF Purdue Pharma L.P. (US) 2016-12-07 EP disclosed
EP-0128006-A2 A soil-disease-controlling agent SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-12-12 EP disclosed
EP-0000555-B1 PROCESS FOR THE PREPARATION OF OXIRANES SUBSTITUTED BY HALOGEN ALKYL BAYER AG (DE) 1982-02-10 EP disclosed
US-4228295-A Novel cycloheptathiophene intermediates for the synthesis of biotin HOFFMANN-LA ROCHE INC. (US) 1980-10-14 US disclosed
US-4228168-A ANTI-ANOXIC ACTIVITY TANABE SEIYAKU CO., LTD. (JP) 1980-10-14 US disclosed
US-4175086-A Cycloheptathiophene derivatives HOFFMANN-LA ROCHE INC. (US) 1979-11-20 US disclosed
EP-0000554-A1 Process for the preparation of oxiranes substituted by halogen alkyl BAYER AG (DE) 1979-02-07 EP disclosed
US-4124595-A Synthesis of biotin HOFFMANN-LA ROCHE INC. (US) 1978-11-07 US disclosed
US-4062868-A Synthesis of biotin HOFFMANN-LA ROCHE INC. (US) 1977-12-13 US disclosed
US-4017539-A Biguanide compounds and anti-diabetic compositions BOEHRINGER MANNHEIM G.M.B.H. (DT) 1977-04-12 US disclosed